Barriers and facilitators to opioid agonist treatment (OAT) engagement among individuals released from federal incarceration into the community in Ontario, Canada
- PMID: 35787743
- PMCID: PMC9258049
- DOI: 10.1080/17482631.2022.2094111
Barriers and facilitators to opioid agonist treatment (OAT) engagement among individuals released from federal incarceration into the community in Ontario, Canada
Abstract
Introduction: Correctional populations with opioid use disorder experience increased health risks during community transition periods. Opioid Agonist Treatment (OAT) can reduce these risks, but retention is a key challenge. This study addresses a knowledge gap by describing facilitators and barriers to OAT engagement among federal correctional populations released into the community in Ontario, Canada.
Methods: This article describes results from a longitudinal mixed-methods study examining OAT transition experiences among thirty-five individuals released from federal incarceration in Ontario, Canada. Assessments were completed within one year of participants' release. Data were thematically analyzed.
Results: The majority (77%) of participants remained engaged in OAT, however, 69% had their release suspended and 49% returned to custody. Key facilitators for OAT engagement included flexibility, positive staff rapport, and structure. Fragmented OAT transitions, financial OAT coverage, balancing reintegration requirements, logistical challenges, and inaccessibility of 'take-home' OAT medications were common barriers.
Conclusions: Post-incarceration transition periods are critical for OAT retention, yet individuals in Ontario experience barriers to OAT engagement that contribute to treatment disruptions and related risks such as relapse and/or re-incarceration. Additional measures to support community OAT transitions are required, including improved discharge planning, amendments to OAT and financial coverage policies, and an expansion of OAT options.
Keywords: Addiction; Canada; community release; corrections; opioid agonist treatment; opioid use disorder; parole; prison; re-incarceration; re-integration; substance use.
Conflict of interest statement
No potential conflict of interest was reported by the author(s).
References
-
- Ahamad, K., Milloy, M. J., Nguyen, P., Uhlmann, S., Johnson, C., Korthuis, T. P., Kerr, T., & Wood, E. (2015). Factors associated with willingness to take extended release naltrexone among injection drug users. Addiction Science & Clinical Practice, 10(1), 12. 10.1186/s13722-015-0034-5 - DOI - PMC - PubMed
-
- Akinsemolu, A., Ogston, S., & Irvine, L. (2011). P2-354 Effectiveness of opioid substitution therapy among prisoners with drug dependence: A meta analysis. Journal of Epidemiology & Community Health, 65(Suppl 1), A320–A. 10.1136/jech.2011.142976k.86 - DOI
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous